Crowdonomics
WatchlistPortfolio
SynergyMed Cancer Treatment Technology

Reg CF · SAFE · Nov 2024

ClosedReached targetReg CFSAFE
via WeFunderView campaign
Raised
$698K / $1.2M max
57% of ceiling · target hit day 10
Investors
—
—
Valuation cap
$16M
cap, not an agreed valuation

Raised over time

Cumulative raisedInvestors
$698K$349K$0
5252630
Nov 10, 2024 · openedFeb 4, 2026 · last reading
Target ($50K) hit — Nov 20, 2024, day 10Deadline Apr 30, 2026 — 85 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$0
−$21K
FY2022
$0
−$23K
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$21,499
-$23,178
Taxes paid
$0
$0
Balance sheet
Cash
$65,920
$40,984
Accounts receivable
$0
$0
Total assets
$69,991
$48,713
Short-term debt
$0
$1,900
Long-term debt
$0
$0
Total liabilities
$0
$1,900
Other
Headcount
—
1

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Apr 30, 2025
    • Deadline Apr 30, 2025 → Apr 30, 2026

    “Adding in 2024 financials and extending close date.”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Valuation cap$16M ($14.4M early bird)

Perks

First $100K of investments will be in a safe with a $14.4M valuation cap and 10% discountfirst $100K

Offering details

Target$50,000
Max$1,235,000
Min investment$100
OpenedNov 10, 2024
DeadlineApr 30, 2026
ClosedFeb 4, 2026
Days active451

Links & provenance

Campaign pageSEC filing
Source: Manual
0001670254-24-001055

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.